Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus-Reference-Cited by-同舟云学术

Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus

Published:2012-12 Issue:3-4 Volume:160 Page:277-289
ISSN:0378-1135
Container-title:Veterinary Microbiology
language:en
Short-container-title:Veterinary Microbiology

Author:

Moon Ho-Jin,Lee Jong-Soo,Talactac Melbourne R.,Chowdhury Mohammed Y.E.,Kim Jae-Hoon,Park Min-Eun,Choi Young-Ki,Sung Moon-Hee,Kim Chul-Joong

Funder

National Agenda Project

Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea

Chungnam National University

Publisher

Elsevier BV

Subject

General Veterinary,General Medicine,Microbiology

Reference44 articles.

1. In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly (γ-glutamic acid);Akagi;Macromol. Biosci.,2005

2. Multifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly (γ-glutamic acid);Akagi;J. Biomater. Sci. Polym. Ed.,2006

3. Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant;Andreakos;Proc. Natl. Acad. Sci. U.S.A.,2006

4. Neutralization enzyme immunoassay for influenza virus;Benne;J. Clin. Microbiol.,1994

5. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice;Brazolot Millan;Proc. Natl. Acad. Sci. U.S.A.,1998

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Vectors and Administrations for mRNA Delivery;Small;2023-07-20

2. Pulmonary Application of Novel Antigen-Loaded Chitosan Nano-Particles Co-Administered with the Mucosal Adjuvant C-Di-AMP Resulted in Enhanced Immune Stimulation and Dose Sparing Capacity;Pharmaceutics;2023-04-13

3. Immunologically effective biomaterials-enhanced vaccines against infection of pathogenic microorganisms;Biosafety and Health;2023-02

4. Efficacy of a Novel Multiepitope Vaccine Candidate against Foot-and-Mouth Disease Virus Serotype O and A;Vaccines;2022-12-19

5. The evolution of the global COVID-19 epidemic in Morocco and understanding the different therapeutic approaches of chitosan in the control of the pandemic;Polymer Bulletin;2022-11-21